Women experience greater weight loss with tirzepatide compared to men

All doses of tirzepatide, a medication approved in the EU to treat type 2 diabetes and obesity, consistently reduced body weight in women and men, but women experienced greater weight loss, according to new post hoc research to be presented at this year’s Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept).

IPG Health debuts new clinical trial diversity approach based on experience and spurred by pharma requests

IPG Health is aiming to boost the call for more diversity in clinical trials with a new multi-disciplinary approach for pharma clients. Based on its

September 8, 2023

Are you affected by the Trump administration’s pause on health communications, science meetings, and reviews?

The Trump administration has put a temporary freeze on many federal health and science agency affairs. In response, agencies have prohibited employees from communicating with the

January 25, 2025

Newly identified ‘headspin hole’ affects breakdancers’ scalp health

Breakdancers may be at risk of developing a condition caused by repeatedly doing a cardinal move of their practice and performance-;the headspin-;warn doctors in the

October 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.